Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway

Munkhtuya Tumurkhuu1, Makiko Saitoh, Atsushi Sato

  • 1Department of Developmental Medical Sciences, Institute of International Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Abstract

Insights

Genetic analysis of RAS/RAF/MEK/ERK pathway mutations revealed a novel SOS1 substitution in a Costello syndrome/cardio-facio-cutaneous syndrome patient, highlighting genotype-phenotype complexity in related genetic disorders.

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Genetics

Background:

  • Germline mutations in the RAS/RAF/MEK/ERK pathway cause overlapping genetic disorders like Noonan syndrome (NS), Costello syndrome (CS), and cardio-facio-cutaneous syndrome (CFC).
  • These syndromes present with similar clinical features but have diverse molecular underpinnings.
  • Comprehensive genetic analysis is crucial for understanding their etiology.

Purpose of the Study:

  • To perform a detailed genetic investigation of the RAS/RAF/MEK/ERK pathway in patients with NS, CS, and CFC.
  • To identify specific gene mutations contributing to the phenotypes of these related syndromes.
  • To elucidate the genotype-phenotype correlations within this group of genetic disorders.

Main Methods:

  • Analysis of peripheral blood samples from three NS patients and two CS/CFC patients.
  • Genetic screening of key pathway genes including PTPN11, KRAS, HRAS, NRAS, BRAF, RAF1, SOS1, and MEK1.
  • Comparison with genetic data from 100 healthy Japanese volunteers.

Main Results:

  • A rare PTPN11 mutation (N58D) was identified in a patient with a severe Noonan phenotype.
  • A novel SOS1 missense mutation (T158A) was discovered in a CS/CFC patient, with no HRAS mutations detected.
  • This SOS1 mutation has not been previously reported in CS.

Conclusions:

  • The identification of SOS1 T158A in a CS-like case underscores the complex relationship between genotype and phenotype in RAS/RAF/MEK/ERK pathway syndromes.
  • This finding expands the known genetic spectrum of CS/CFC.
  • Further research is needed to fully understand the implications of novel mutations in these overlapping syndromes.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: